Our Pros Weigh In On Whether Palantir Stock Can Hit $200
This week’s sentiment survey will tell us where our team stands on the stock market before digging in on Tesla, SpaceX, and Palantir. Plus, why your 401(k) may be invested in the wrong things.
Slowing Market Offers Glimpse of Near Future
Without any catalysts on the horizon, Monday offered a taste of what’s to come.
I’m Eyeing 2 Biopharma Stocks Amid Choppy Market Action
These small-cap biotechs offer core businesses that fund a much bigger opportunity.
Meta Joins OpenAI, Anthropic With High-Profile Hack: 8 Key Items Shaping the Stock Market Thursday
SpaceX IPO lockup expiration begins, Fed blowback and other headlines moving stocks this morning.
We’re Raising Our Apple Price Target After iPhone Share Gains
We could see Apple’s iOS 27 public beta released this week.